Establishment Labs Holdings (Establishment Labs Holdings) Interest Coverage : 0 (At Loss) (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Establishment Labs Holdings Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Establishment Labs Holdings's Operating Income for the three months ended in Mar. 2024 was $-8.8 Mil. Establishment Labs Holdings's Interest Expense for the three months ended in Mar. 2024 was $-4.4 Mil. did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is.

The historical rank and industry rank for Establishment Labs Holdings's Interest Coverage or its related term are showing as below:

ESTA's Interest Coverage is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 17.89
* Ranked among companies with meaningful Interest Coverage only.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Establishment Labs Holdings Interest Coverage Historical Data

The historical data trend for Establishment Labs Holdings's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Establishment Labs Holdings Interest Coverage Chart

Establishment Labs Holdings Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Coverage

Get a 7-Day Free Trial

Establishment Labs Holdings Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Coverage	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Establishment Labs Holdings's Interest Coverage

For the Medical Devices subindustry, Establishment Labs Holdings's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Establishment Labs Holdings's Interest Coverage Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Establishment Labs Holdings's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Establishment Labs Holdings's Interest Coverage falls into.

Establishment Labs Holdings Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage

-1

Operating Income

Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt ⁽¹⁾.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Establishment Labs Holdings's Interest Coverage for the fiscal year that ended in Dec. 2023 is calculated as

Here, for the fiscal year that ended in Dec. 2023, Establishment Labs Holdings's Interest Expense was $-15.4 Mil. Its Operating Income was $-65.0 Mil. And its Long-Term Debt & Capital Lease Obligation was $191.5 Mil.

Establishment Labs Holdings did not have earnings to cover the interest expense.

Establishment Labs Holdings's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Here, for the three months ended in Mar. 2024, Establishment Labs Holdings's Interest Expense was $-4.4 Mil. Its Operating Income was $-8.8 Mil. And its Long-Term Debt & Capital Lease Obligation was $195.4 Mil.

Establishment Labs Holdings did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's Financial Strength is.

Establishment Labs Holdings (NAS:ESTA) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .

Establishment Labs Holdings Interest Coverage Related Terms

Thank you for viewing the detailed overview of Establishment Labs Holdings's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.

Establishment Labs Holdings (Establishment Labs Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Establishment Labs Holdings Inc (NAS:ESTA) » Definitions » Interest Coverage

Comparable Companies

Traded in Other Exchanges

3E0:Germany

Address

Coyol Free Zone, Building B15 and 25, Alajuela, CRI

Website

https://establishmentlabs.com

Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in designing, manufacturing, and marketing silicone-filled breast and body shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.

Executives

Nicholas Sheridan Lewin	director, 10 percent owner	3 WEST 57TH ST., 8TH FLOOR, NEW YORK NY 10019
Raj Denhoy	officer: Chief Financial Officer	C/O MOTIVA USA, LLC, 16192 COASTAL HIGHWAY, LEWES DE 19958
Dennis E Condon	director	811 ALSTON RD, SANTA BARBARA CA 93108
Leslie Gillin	director	C/O MOTIVA USA, LLC, 16192 COASTAL HIGHWAY, LEWES DE 19958
Paul D. Rodio	officer: Chief Operating Officer	C/O MOTIVA USA LLC, 16192 COASTAL HIGHWAY, LEWES DE 19958
Samuel Ross Mansbach	other: GC & Chief Compliance Officer	C/O MOTIVA USA LLC, 16192 COASTAL HIGHWAY, LEWES DE 19958
Jw Asset Management, Llc	10 percent owner, other: See Footnote(1)	1051 N VENETIAN DRIVE, MIAMI BEACH FL 33139
Bryan Slotkin	director	C/O MOTIVA USA,.LLC, 16192 COASTAL HIGHWAY, LEWES DE 19958
Ann Custin	director	C/O MOTIVA USA, LLC, 16192 COASTAL HIGHWAY, LEWES DE 19958
Edward J Schutter	director	C/O FIRST HORIZON PHARMACEUTICAL CORP, 6195 SHILOH ROAD, ALPHARETTA GA 30005
Lisa Gersh	director	C/O HASBRO, INC., 1011 NEWPORT AVENUE, PAWTUCKET RI 02861
Mezerville Roberto De	officer: Chief Technology Officer	C/O MOTIVA USA LLC, 16192 COASTAL HIGHWAY, LEWES DE 19958
Renee Gaeta	officer: Chief Financial Officer	C/O MOTIVA USA LLC, 16192 COASTAL HIGHWAY, LEWES DE 19958
Pratip Dastidar	officer: Head of Global Operations	150 PEABODY PLACE, MEMPHIS TN 38103
Santos Salvador Dada	officer: Chief Operating Officer	C/O MOTIVA USA LLC, 16192 COASTAL HIGHWAY, LEWES DE 19958